Regional Cancer Centre Stockholm Gotland Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2016
NCT02948309
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Regional Cancer Centre Stockholm Gotland